U.S. market Closed. Opens in 16 hours 16 minutes

VTGN | VistaGen Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312010-12-312009-12-312008-12-312007-12-31
Revenue1.06M-227.00K1.11M1.09MN/AN/AN/A1.25MN/AN/AN/A200.40K1.34MN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A103.10K91.20K80.70KN/A53.50KN/AN/A3.43MN/AN/AN/AN/AN/A
Gross Profit1.06M-227.00K1.11M1.09MN/A-91.20K-80.70K1.25M-53.50KN/AN/A-3.23M1.34MN/AN/AN/AN/A
Operating Expenses34.09M59.04M48.89M19.02M19.97M24.53M14.20M11.07M17.85M6.68M5.03M6.49M10.39M8.95K21.97K16.39K4.78K
Selling, General & Admin14.06M14.66M13.25M7.10M6.60M7.43M6.44M5.87M13.92M4.25M2.55M3.06M5.00M8.52K21.54K16.35K4.78K
Research & Development20.02M44.38M35.41M11.93M13.37M17.10M7.76M5.20M3.93M2.43M2.48M3.43M5.39MN/AN/AN/AN/A
Other Operating ExpensesN/AN/A232.00K-400.00-827.00K-48.70K-428.00K-427.00K-2.30K-233.00KN/A-472.60KN/A428.00428.0036.00N/A
Operating Income-33.02M-59.27M-47.78M-17.93M-20.80M-24.56M-14.20M-10.25M-17.85M-6.78M-5.03M-6.79M-9.04M-8.95K-21.97K-16.39K-4.78K
Other Expenses / Income3.66M26.00K19.90K2.20K30.10K-30.70K-143.90K-4.60K-29.37M-7.11M2.06M-6.09M-3.91M-9.47MN/AN/AN/A
Before Tax Income-29.36M-59.24M-47.76M-17.93M-20.77M-24.59M-14.34M-10.25M-47.22M-13.88M-2.96M-12.88M-12.21M-8.95K-21.97K-16.39K-4.78K
Income Tax Expenses4.00K6.00K3.40K2.60K2.60K2.60K2.40K2.40K2.30K2.40K2.70K3.70K1.60K30.0030.0030.00-30.00
Net Income-29.36M-59.25M-47.76M-17.93M-20.77M-24.59M-14.35M-10.26M-47.22M-13.89M-2.97M-12.89M-12.21M-8.98K-22.00K-16.42K-4.75K
Interest ExpensesN/A23.00KN/A13.00K15.00K8.00K8.90K5.00K777.00K4.62M1.56M1.00M1.89MN/AN/AN/AN/A
Basic Shares Outstanding19.35M6.96M6.60M2.87M1.46M952.08K463.00K251.05K58.93K43.63K39.85K30.18K24.56K19.50K19.50K17.34K17.00K
Diluted Shares Outstanding19.35M6.96M6.60M2.87M1.46M952.08K463.00K251.05K58.93K43.96K36.64K30.18K24.56K19.50K19.50K17.34K17.00K
EBITDA-32.45M-58.74M-47.05M-17.44M-20.65M-24.47M-14.25M-10.19M-17.80M-6.72M-4.97M-11.93M-10.27M-6.32M-21.54K-16.35K-4.78K
EBITDA Margin-3,050.09%25,874.89%-4,242.75%-1,600.83%0.00%0.00%0.00%-815.49%0.00%0.00%0.00%-5,955.34%-765.09%0.00%0.00%0.00%0.00%
EBIT-29.36M-59.22M-47.76M-17.92M-20.76M-24.58M-14.33M-10.25M-46.44M-9.27M-1.40M-11.88M-10.31M-8.95K-21.97K-16.39K-4.78K
EBIT Margin-2,759.21%26,087.67%-4,306.88%-1,644.66%0.00%0.00%0.00%-819.85%0.00%0.00%0.00%-5,927.64%-768.49%0.00%0.00%0.00%0.00%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙